drugset / Trial / NCT00801268

Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease

NCT00801268 ↗

Terminated 300 enrolled Zhi-Hong Liu, M.D.
RandomizedFactorialOpen-labelTreatment

Summary

Triptolide has been approve effective in animal model.

Timeline

Start
2008-11
Primary completion
2013-11
Completion
2013-11

Outcome

Outcome not reported

Stopped: “high rate of drop-out”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Emodin Small molecule 100 mg —
Subject tripterygium wilfordii Traditional medicine (herbal / TCM) 60 mg —